Lv1
28 积分 2025-05-28 加入
Lessons learned in linking PROTACs from discovery to the clinic
5天前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
28天前
已完结
Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4
1个月前
已完结
Discovery of APH02174 as a Highly Selective and Orally Bioavailable IRAK4 Degrader for the Treatment of Inflammatory Diseases
1个月前
已完结
Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors
1个月前
已完结
Biophysical investigations of the membrane interactions of collagen VI-derived host defense peptides
2个月前
已完结
Bioengineered protein nanocarrier facilitating siRNA escape from lysosomes for targeted RNAi therapy in glioblastoma
3个月前
已完结
Design of one-component quasisymmetric protein nanocages
3个月前
已完结
Self-assembling protein nanoparticles for cytosolic delivery of nucleic acids and proteins
3个月前
已完结
Genetically Encoded Elastin-Like Polypeptides for Drug Delivery
3个月前
已完结
皖公网安备34019202002308
